19.75

0.95% 0.185

Innoviva Inc (INVA)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Innoviva Inc stock is traded at $19.75, with a volume of 118.77K. It is up +0.95% in the last 24 hours and up +5.53% over the past month. Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Previous Close:

$19.57

Open:

$19.53

24h Volume:

118.77K

Relative Volume:

0.14

Market Cap:

$1.24B

Revenue:

$330.50M

Net Income/Loss:

$145.42M

P/E Ratio:

11.97

EPS:

1.65

Net Cash Flow:

$157.96M

1W Performance:

+4.14%

1M Performance:

+5.53%

6M Performance:

+3.32%

1Y Performance:

+25.11%

1-Day Range:

$19.51

$19.80

1-Week Range:

$19.01

$19.80

52-Week Range:

$15.55

$21.28

Innoviva Inc Stock (INVA) Company Profile

Name

Innoviva Inc

Sector

Healthcare (1175)

Industry

Biotechnology (667)

Phone

(650) 238-9600

Address

1350 OLD BAYSHORE HIGHWAY, BURLINGAME

Employee

127

Twitter

Next Earnings Date

2025-05-02

Latest SEC Filings

INVA's Discussions on Twitter

Compare INVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INVA Innoviva Inc	19.75	1.20B	330.50M	145.42M	157.96M	1.65
ONC Beone Medicines Ltd Adr	244.57	25.76B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.42	114.53B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.3499	40.54M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	83.43	6.44B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	487.77	65.13B	14.09B	4.50B	2.96B	39.28

Innoviva Inc Stock (INVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Jun-18-24	Initiated	Cantor Fitzgerald	Overweight
Jul-20-22	Initiated	Goldman	Neutral
Nov-20-17	Initiated	Deutsche Bank	Hold

Innoviva Inc Stock (INVA) Latest News

May 29, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $546,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 29, 2025

Ameriprise Financial Inc. Has $2.50 Million Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 29, 2025

May 27, 2025

Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLC - Defense World

May 27, 2025

May 23, 2025

(INVA) Proactive Strategies - news.stocktradersdaily.com

May 23, 2025

May 21, 2025

Innoviva Elects Board Members and Approves Compensation - TipRanks

May 21, 2025

Bank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 21, 2025

May 20, 2025

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections - BioSpace

May 20, 2025

Innoviva (INVA) Launches New Antibiotic ZEVTERA for MRSA Treatme - GuruFocus

May 20, 2025

ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections - marketscreener.com

May 20, 2025

Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times

May 20, 2025

May 19, 2025

Cubist Systematic Strategies LLC Makes New $184,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 19, 2025

May 17, 2025

Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust Corp - Defense World

May 17, 2025

Comerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 17, 2025

May 14, 2025

Armata Completes Crucial Bacteriophage Trial, Lands $4.65M Defense Contract Amid Strong Q1 Results - Stock Titan

May 14, 2025

Envestnet Asset Management Inc. Has $258,000 Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 08, 2025